Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid injection versus exercise therapy for persistent shoulder pain
NL-OMON52854Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Dec 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in shoulder pain and Shoulder disorder (2 arms), sponsored by Erasmus MC. Primary endpoint: SPADI total score over 12 months. Started Dec 2020; status: completed.
02
Conditions
shoulder painShoulder disorder
Beyond the preview
Go deeper on NL-OMON52854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52854.